s6y

4 Sage Therapeutics, Inc.: Statement of changes in beneficial ownership of securities

Filed
Period
Accession number
0001562180-22-003565

Documents

  1. PRIMARY DOCUMENT 4
  2. JEFF JONAS 2019 POA EX-24

On sec.gov